Thirteen studies were included, of which 12 were full accounts and 1 was an abstract. Eight studies compared post-operative prophylaxis with a control group, and the other 5 studies were randomised comparisons of different prophylaxis methods. Two of the studies included a comparison of 2 dosing schedules for the same medication. Five studies evaluated post-operative prophylaxis by mechanical devices, and 9 evaluated pharmacological methods; 1 study evaluated both mechanical devices and pharmacological methods.
Studies comparing the efficacy of post-operative application of mechanical devices with findings in an untreated control group (intermittent pneumatic compression of the calf, or of the calf and thigh combined) led to clinically important reductions of VTE in neurosurgical and orthopaedic patients with RR of 0.18 (95% confidence interval, CI: 0.004, 1.34) and 0.49 (95% CI: 0.35, 0.69).
Of the controlled studies that used pharmacological prophylaxis, 2 evaluating the efficacy of post-operative low-molecular-weight heparin (LMWH) therapy found a clinically important and statistically-significant reduction in rates of VTE after hip and knee replacement, with RR of 0.16 (95% CI: 0.04, 0.48) and 0.30 (95% CI: 0.14, 0.57).
Bleeding rates in the larger comparison studies showed a statistically-significant increase in patients who underwent hip replacement and who received 7500 U of standard heparin twice daily, compared with 30 mg enoxaparin twice daily (p=0.04). Major bleeding (p=0.04) and wound haematomas (p=0.01), but not minor bleeding, were more common in patients who underwent hip and knee replacement and received logiparin, 75 U/kg anti-Xa once a day, compared with warfarin.